Focal Segmental Glomerulosclerosis (FSGS): Causes, Pathology, and Clinical Impact
Focal segmental glomerulosclerosis (FSGS) is a histologic pattern of glomerular injury — not a single disease — defined by segmental (partial) sclerosis (scarring) affecting some (focal) glomeruli. It is a leading cause of nephrotic syndrome and CKD/ESRD.
Classification
| Category | Examples |
|---|---|
| Primary (Idiopathic) | No identifiable cause. Presumed circulating permeability factor (e.g., suPAR). Often steroid-resistant. |
| Secondary / Adaptive | Hyperfiltration from reduced nephron mass: obesity, prematurity, unilateral renal agenesis, reflux nephropathy, sickle cell, HIV (collapsing variant). |
| Genetic | NPHS2 (podocin), ACTN4, TRPC6, INF2. Early onset, familial, steroid-resistant. |
| Drug/Toxin-Induced | Pamidronate, sirolimus, anabolic steroids, heroin, lithium. |
| Viral | HIV (collapsing FSGS), parvovirus B19. |
Histologic Variants (Columbia Classification)
- Collapsing: Worst prognosis. Podocyte hyperplasia, capillary collapse. HIV, pamidronate, genetic.
- Tip: Best steroid response. Sclerosis at tubular pole.
- Cellular: Endocapillary hypercellularity.
- Perihilar: Sclerosis at vascular pole. Common in adaptive.
- Not Otherwise Specified (NOS): Most common.
Clinical Presentation
- Nephrotic syndrome (heavy proteinuria >3.5 g/day, hypoalbuminemia, edema, hyperlipidemia) — 70% primary.
- Subnephrotic proteinuria + microscopic hematuria + hypertension + declining GFR — secondary/genetic.
Diagnosis and Management
- Renal biopsy required (LM, IF, EM). EM: foot process effacement (>80%).
- Genetic testing if early onset, family history, steroid-resistant.
- Primary FSGS: High-dose prednisone (16 weeks) → if resistant: calcineurin inhibitors (tacrolimus, cyclosporine), rituximab, mycophenolate, ACTH gel.
- Secondary: Treat underlying cause + RAAS blockade (ACEi/ARB) — cornerstone.
- Recurrence post-transplant: 30–50% (primary); plasmapheresis + rituximab prophylaxis.
FSGS is a spectrum. Accurate classification guides therapy and prognosis. Early RAAS blockade slows progression in all forms.
Multiple Sclerosis - Related Articles
- Multiple Sclerosis in Children: Symptoms, Diagnosis & Understanding
- Multiple Sclerosis and Heat Sensitivity: Uhthoff Phenomenon, Relapse Risk, and Cooling Strategies
- Post-Scabies Skin Changes: New Bumps After Treatment – Causes and Reassurance
- Understanding Multiple Sclerosis: Symptoms, Impact, and Preparation
- Multiple Sclerosis (MS): Understanding the Disease & Its Impact
- Understanding Multiple Sclerosis Progression: Types, Symptoms, and the EDSS Scale
- Multiple Sclerosis (MS): Symptoms, Causes & Understanding
